News
December 28, 2018
Hope on the Hill Congressional Dinner Raises $200,000
The 8th Annual “Hope on the Hill” Congressional Dinner was held on Tuesday, November 27, 2018 at The Willard Hotel in Washington, DC. More than 170 people from the SMA community – including government and industry partners – attended the dinner which raised $200,000 to...
Topics: Our Impact, Advocacy, Front Page News
December 26, 2018
December Webinar on SMA Treatments and Clinical Trials Now Available Online
A recording of the December 13th webinar updating the community on SMA treatments and clinical trials is now available online. A PDF of the webinar presentation is also available for...
Topics: Clinical Trials, Research, Front Page News
December 20, 2018
2018 Research Year-in-Review
Over our past fiscal year—from July 1, 2017, to June 30, 2018—Cure SMA has funded over $5 million in new research funding. This funding will be used strategically to help accelerate research, and ensure we are developing treatments for all types, ages, and stages of SMA. The...
Topics: Our Impact, Research, Front Page News
December 19, 2018
Cure SMA Funding Leads to 16 New Research Publications in 2018
An important goal of our research funding strategy is to share scientific findings with the broader scientific community. Scientists who receive Cure SMA funding often publish their findings in peer-reviewed journals. This means that other scientists can learn from their results, which will pay dividends across the wider landscape of SMA...
Topics: Our Impact, Research, Front Page News
December 18, 2018
Community Spotlight: The Berkovits Family
When Milo Berkovits was seven months old, his daycare teacher noticed he was not reaching his milestones. What followed from there on were visits to three different pediatricians, an early intervention assessment, a review by a private occupational therapist, another assessment by a private...
Topics: Community & Awareness, Front Page News
December 14, 2018
Advocacy Year-in-Review 2018
For Cure SMA, 2018 has been a year of great progress. As we continue to make strides into 2019, it is important to take a moment to look back at all our successes. Thank you to all our families and advocates for your support and continued efforts to cure SMA. We wish you all a very Happy...
Topics: Our Impact, Advocacy, Front Page News
December 13, 2018
Biogen Issues Q4 Community Statement on Spinraza
Bigoen has provided the below community statement on Spinraza.
Dear Members of the SMA community,
As we approach the two-year anniversary of the U.S. Food and Drug Administration’s (FDA) approval of SPINRAZA® (nusinersen), we want to thank you for your ongoing...
Topics: Clinical Trials, Research, Front Page News
December 12, 2018
AveXis Issues Community Statement on BLA Acceptance
AveXis has provided the following community statement on the BLA submission and acceptance for their investigational therapy, AVXS-101 - now known as ZOLGENSMA®.
Dear SMA Community,
We are providing this update to the SMA community in the U.S. at the request of Cure SMA....
Topics: Clinical Trials, Research, Front Page News
December 10, 2018
Closing out 2018 with Good News: Virginia Adopts SMA to their Newborn Screening Panel, Arizona Moves Closer to Adopting SMA Newborn Screening and Illinois Medicaid Covers Spinraza Treatment
The SMA community has multiple victories to celebrate as the year comes to an end. Thank you to all our amazing families and advocates who have and continue to make this progress possible.
Virginia Adopts SMA Newborn Screening
Last month, Virginia’s Newborn Screening...
Topics: Community & Awareness, Advocacy, Front Page News
December 4, 2018
Fall 2018 Issue of Compass Now Available
The fall 2018 issue of Compass is now available online.
This issue of Compass covers the SMA Care Center Network and its goal of developing an evidence-based standard of care to improve the lives of people with...
Topics: Support & Care, Our Impact, Front Page News